Positives

• Patients with chronic inflammatory pain appreciate piroxicam's once-daily dosing, which they describe as easier to maintain than three or four times daily NSAIDs, per the Arthritis Foundation's NSAID guide.
  
  
• Long-acting cyclooxygenase inhibition is described by patients as providing more even pain control through the day and night versus shorter NSAIDs, per Mayo Clinic's piroxicam monograph.
  
  

Negatives

• Piroxicam carries a higher relative risk of GI bleeding than other NSAIDs, with patients reporting cramping, ulcers, and gastrointestinal bleeding even at low doses, per NCBI LiverTox piroxicam entry.
  
  
• Patients commonly describe heartburn, edema, blood pressure rise, and tinnitus that can mimic worsening Long COVID symptoms, per WebMD's piroxicam page.
  
  

Hurdles & Side Effects

• US prescribers have largely moved away from piroxicam toward better-tolerated NSAIDs, leaving fewer than 200,000 prescriptions per year and patients sometimes facing pharmacy stocking delays, per the same NCBI LiverTox piroxicam monograph.
  
  
• Patients with cardiovascular risk factors face explicit warnings of increased fatal heart attack and stroke, particularly relevant to those with post-COVID cardiovascular changes, per the FDA's Feldene label.